ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients

• Published in: Radiation oncology (London, England) Vol. 14; no. 1; p. 192
• Main Authors: Chen, Ying, Xie, Tieming, Ye, Zhimin, Wang, Fangzheng, Long, Dan, Jiang, Mingxiang, Fang, Jun, Lin, Qingren, Li, Kai, Wang, Zhun, Fu, Zhenfu
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 04.11.2019; BioMed Central; BMC
• Subjects: Adult; Apparent diffused coefficient; Carcinoma; Care and treatment; Chemoradiotherapy; Diagnostic imaging; Diffused weighed imaging; Diffusion Magnetic Resonance Imaging - methods; Driving while intoxicated; Early response; Esophageal cancer; Esophageal carcinoma; Esophageal Neoplasms - chemistry; Esophageal Neoplasms - diagnostic imaging; Esophageal Neoplasms - therapy; Esophageal Squamous Cell Carcinoma - chemistry; Esophageal Squamous Cell Carcinoma - diagnostic imaging; Esophageal Squamous Cell Carcinoma - therapy; Female; Humans; Immunohistochemistry; Logistic Models; Male; Medical research; Middle Aged; Radiotherapy; ROC Curve; Sirtuin 1 - analysis; Sirtuin1; Squamous cell carcinoma; Tumors; Taiwan; Early response; Esophageal carcinoma; Apparent diffused coefficient; Diffused weighed imaging; Sirtuin1
• ISSN: 1748-717X; 1748-717X
• DOI: 10.1186/s13014-019-1393-y

To determine the biological correlation between apparent diffusion coefficient (ADC) values and Sirtuin1 (SIRT1) levels of tumour tissues in patients with esophageal carcinoma (EC), and to ascertain the treatment biomarker of ADC in predicting the early response of patients undergoing definitive chemoradiotherapy (CRT). A total of 66 patients were enrolled, and the specimens of tumour tissues were collected before treatment to perform immunohistochemical (IHC) examinations and quantify the levels of SIRT1. Then all patients were given two esophageal magnetic resonance imaging (MRI) examinations with diffused weighed imaging (DWI) including pretreatment and intra-treatment (1~2 weeks after the start of radiotherapy). The regions of interest (ROIs) were contoured according to the stipulated rules in advance using off-line software, and the values of the ADC in the ROIs were generated automatically. Then, the values of the ADC at baseline and intra-treatment were labeled as pre-ADC and intra-ADC respectively, and ΔADC, ADC were calculated. Pearson's correlation coefficients were acquired to estimate the correlation between each of ADC values and SIRT1 levels. Spearman's rank correlation coefficients were acquired to estimate the correlation between early response and the values of each ADC. Receptor operation characteristics (ROC) curves were constructed to estimate the accuracy of the ADC in predicting the early response of CRT. The findings of this study showed different correlations between ADC values and the levels of SIRT1 (ΔADC: r = - 0.943, P = 0.002; ADC : r = - 0.911, P = 0.000; intra-ADC: r = - 0.748, P = 0.002; pre-ADC: r = 0.109, P = 0.558). There was a positive correlation between ΔADC and early response to treatment (ρ = 0.615, P = 0.023), and multivariable logistic regression revealed that ΔADC was significantly associated with short-term response of CRT in esophageal carcinoma patients. In summary, early increases in ADC may facilitate the predication of early CRT response in patients with esophageal squamous cell carcinoma (ESCC), which may be attributed to the different correlation between ADC changes and SIRT1 expression.